CYH vs THC Stock Comparison: AI Score, Valuation, Performance and Upside
CYH (Community Health Systems) and THC (Tenet Healthcare) are both large for-profit hospital operators, but with very different financial situations and market positioning — CYH operates primarily in non-urban markets with higher financial leverage, while Tenet operates in better payer-mix urban/suburban markets with a higher-growth ambulatory surgery center business through USPI.
CYH vs THC compares two challenged for-profit hospital operators at different quality tiers — Community Health Systems' distressed but potentially recovering non-urban hospital portfolio versus Tenet's stronger urban hospitals and growing high-margin ambulatory surgery business.
THC holds the edge across 5 of 5 key metrics in this comparison. THC leads on both 1-year return (+37.68%) and forward P/E quality (12.26x vs -5.59x for CYH), a relatively favorable combination of momentum and valuation. THC leads on both revenue growth (6.80%) and operating margin (18.16%), suggesting a stronger fundamental setup on both dimensions. Analyst consensus implies similar upside for both: +9.80% for CYH and +10.28% for THC.
Human Wall Street analysts' price targets, typically implying a ~12-month view — a separate signal from this site's own AI Prediction Signal further down the page, which is a 5-/30-day machine-learning forecast based on price history alone.
- Want high-leverage turnaround exposure to non-urban hospital operations with potentially significant upside if debt is reduced
- Believe supplemental Medicaid payments and government healthcare support will sustain rural hospital economics
- Are comfortable with significant financial and operational risk in exchange for a deeply discounted valuation
- Want for-profit hospital operator exposure with the additional benefit of USPI's ambulatory surgery center growth business
- Value Tenet's better urban/suburban payer mix and higher-margin ambulatory strategy versus pure hospital operators
- See USPI monetization as a potential catalyst for deleveraging and value realization in Tenet's sum-of-parts valuation
| Metric | CYH | THC |
|---|---|---|
| AI scorei | 24.8 | 64.3 |
| AI ranki | #3062 | #90 |
| Latest closei | $2.87 | $261.99 |
| 1M returni | -1.71% | -2.43% |
| 6M returni | -0.69% | +27.73% |
| 1Y returni | -6.82% | +37.68% |
How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?
| Period | CYH | THC |
|---|---|---|
| 1Y ago | $9.32K (-6.8%) started 2025-09-18 | $13.77K (+37.7%) started 2025-09-18 |
| 5Y ago | $2.66K (-73.4%) started 2021-09-20 | $36.48K (+264.8%) started 2021-09-20 |
| 10Y ago | $2.59K (-74.1%) started 2016-09-19 | $113.71K (+1037.1%) started 2016-09-19 |
Hypothetical — past performance does not guarantee future results.
| Metric | CYH | THC |
|---|---|---|
| Market capi | $408.22M | $20.82B |
| Trailing P/Ei | 1.56 | 9.99 |
| Forward P/Ei | -5.59 | 12.26 |
| Price/Salesi | N/A | N/A |
| EV/Revenuei | 0.92 | 1.65 |
| Analyst targeti | $3.18 | $285.10 |
| Target upsidei | +9.80% | +10.28% |
| Metric | CYH | THC |
|---|---|---|
| Revenue growthi | -9.80% | 6.80% |
| Earnings growthi | -75.60% | 213.40% |
| EPS growthi | -75.60% | +213.40% |
| FCF margini | +1.65% | +10.31% |
| Operating margini | 7.68% | 18.16% |
| Profit margini | 2.10% | 10.27% |
| ROIC proxyi | N/A | 37.34% |
| Return on equityi | N/A | 37.34% |
| Dividend yieldi | N/A | N/A |
| Payout ratioi | 0.00% | 0.00% |
| Dividend growth streaki | N/A | N/A |
| Betai | 1.86 | 1.23 |
| Debt/equityi | N/A | 152.28 |
| Current ratioi | 1.53 | 1.41 |
| Quick ratioi | 1.20 | 1.15 |
Over the past year, CYH and THC have moved weakly in the same direction (correlation of 0.33), based on daily returns.
Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.
| Period | Metric | CYH | THC |
|---|---|---|---|
| 1Y | Growthi | -6.82% | +37.68% |
| CAGRi | -6.82% | +37.71% | |
| Volatilityi | 56.18% | 43.27% | |
| Sharpe ratioi | 0.07 | 0.85 | |
| Sortino ratioi | 0.10 | 1.52 | |
| Max drawdowni | 43.54% | 34.08% | |
| Current drawdowni | 34.92% | 6.69% | |
| Avg drawdowni | 25.70% | 11.37% | |
| Ulcer Indexi | 27.75% | 14.96% | |
| Max daily dropi | 13.66% | 5.71% | |
| Max wkly dropi | 20.45% | 13.37% | |
| 5Y | Growthi | -73.43% | +264.79% |
| CAGRi | -23.31% | +29.58% | |
| Volatilityi | 78.27% | 45.20% | |
| Sharpe ratioi | 0.00 | 0.71 | |
| Sortino ratioi | 0.00 | 1.02 | |
| Max drawdowni | 86.28% | 58.88% | |
| Current drawdowni | 80.79% | 6.69% | |
| Avg drawdowni | 68.37% | 16.63% | |
| Ulcer Indexi | 71.56% | 22.20% | |
| Max daily dropi | 42.86% | 30.96% | |
| Max wkly dropi | 44.14% | 28.74% | |
| 10Y | Growthi | -74.12% | +1037.11% |
| CAGRi | -12.65% | +27.53% | |
| Volatilityi | 82.92% | 56.56% | |
| Sharpe ratioi | 0.20 | 0.63 | |
| Sortino ratioi | 0.30 | 0.95 | |
| Max drawdowni | 87.69% | 71.68% | |
| Current drawdowni | 82.76% | 6.69% | |
| Avg drawdowni | 61.32% | 20.87% | |
| Ulcer Indexi | 65.59% | 26.55% | |
| Max daily dropi | 49.65% | 30.96% | |
| Max wkly dropi | 51.77% | 44.92% |
| Category | CYH | THC |
|---|---|---|
| Company | Community Health Systems, Inc. | Tenet Healthcare Corporation |
| Sector | Healthcare | Healthcare |
| Industry | Medical Care Facilities | Medical Care Facilities |
| Core business | Community Health Systems operates a network of acute care hospitals primarily in non-urban and mid-sized markets across the U.S., providing inpatient and outpatient healthcare services to communities with limited access to other hospital care. | Tenet Healthcare operates acute care hospitals, surgical hospitals, and ambulatory surgery centers (through its USPI ambulatory segment), providing healthcare services across a mix of urban and suburban markets with a significant focus on higher-margin ambulatory care. |
| Investor focus | Investors track CYH's same-hospital revenue per adjusted admission trends, operating margins, debt reduction progress, and hospital divestiture strategy as the company reduces its hospital portfolio to improve focus and financial health. | Investors track Tenet's USPI ambulatory surgery center revenue growth, hospital same-facility volume and revenue per patient, EBITDA margin improvements, and leverage reduction through USPI monetization or hospital divestitures. |
- Community hospitals in non-urban markets often have limited local competition, providing a degree of regional market protection
- Government supplemental Medicaid payments (Disproportionate Share Hospital payments) support revenue for hospitals serving high-uninsured populations
- Portfolio rationalization through divesting underperforming hospitals is improving the overall quality and margin profile of remaining facilities
- USPI ambulatory surgery center business operates in higher-margin, faster-growing ambulatory surgery settings rather than just traditional hospital settings
- Urban and suburban market mix provides better payer dynamics than Community Health Systems' non-urban focus
- USPI has been growing through acquisitions of ambulatory surgery centers, a structurally attractive segment as procedures shift from hospitals to ambulatory settings
- Extremely high debt load from historical acquisitions creates significant financial risk in difficult operating environments
- Non-urban markets often have less favorable payer mixes (more Medicaid and uninsured) than urban markets served by HCA and Tenet
- Physician recruitment and nursing staffing challenges in non-urban markets are more acute than at urban hospital systems
- Significant debt load constrains financial flexibility similar to CYH, though Tenet's margins are stronger
- Hospital industry faces ongoing labor cost inflation from nursing travel staffing and specialty physician compensation
- Regulatory and reimbursement uncertainty from government payer programs (Medicare, Medicaid) affects the entire for-profit hospital sector
Want deeper AI forecasts?
This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.